Literature DB >> 30242983

Impacts of misclassification on Lyme disease surveillance.

Heather Rutz1, Brenna Hogan1, Sarah Hook2, Alison Hinckley2, Katherine Feldman1.   

Abstract

In Maryland, Lyme disease (LD) is the most widely reported tickborne disease. All laboratories and healthcare providers are required to report LD cases to the local health department. Given the large volume of LD reports, the nuances of diagnosing and reporting LD, and the effort required for investigations by local health department staff, surveillance for LD is burdensome and subject to underreporting. To determine the degree to which misclassification occurs in Maryland, we reviewed medical records for a sample of LD reports from 2009. We characterized what proportion of suspected and "not a case" reports could be reclassified as confirmed or probable once additional information was obtained from medical record review, explored the reasons for misclassification, and determined multipliers for a more accurate number of LD cases. We reviewed medical records for reports originally classified as suspected (n = 44) and "not a case" (n = 92). Of these 136 records, 31 (23%) suspected cases and "not a case" reports were reclassified. We calculated multipliers and applied them to the case counts from 2009, and estimate an additional 269 confirmed and probable cases, a 13.3% increase. Reasons for misclassification fell into three general categories: lack of clinical or diagnostic information from the provider; surveillance process errors; and incomplete information provided on laboratory reports. These multipliers can be used to calculate a better approximation of the true number of LD cases in Maryland, but these multipliers only account for underreporting due to misclassification, and do not account for cases that are not reported at all (e.g., LD diagnoses based on erythema migrans alone that are not reported) or for cases that are not investigated. Knowing that misclassification of cases occurs during the existing LD surveillance process underscores the complexities of LD surveillance, which further reinforces the need to find alternative approaches to LD surveillance. © Published 2018. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  Lyme disease; misclassification; multipliers; surveillance

Mesh:

Year:  2018        PMID: 30242983     DOI: 10.1111/zph.12525

Source DB:  PubMed          Journal:  Zoonoses Public Health        ISSN: 1863-1959            Impact factor:   2.702


  2 in total

1.  Epidemiology of Lyme borreliosis based on outpatient claims data of all people with statutory health insurance, Germany, 2019.

Authors:  Manas K Akmatov; Jakob Holstiege; Lotte Dammertz; Joachim Heuer; Claudia Kohring; Martin Lotto-Batista; Friedrich Boeing; Stéphane Ghozzi; Stefanie Castell; Jörg Bätzing
Journal:  Euro Surveill       Date:  2022-08

2.  Serology for Borrelia spp. in Northwest Italy: A Climate-Matched 10-Year Trend.

Authors:  Giacomo Stroffolini; Francesco Vladimiro Segala; Tommaso Lupia; Silvia Faraoni; Luca Rossi; Laura Tomassone; Stefania Zanet; Francesco Giuseppe De Rosa; Giovanni Di Perri; Andrea Calcagno
Journal:  Life (Basel)       Date:  2021-11-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.